AUTEN-99

CAS No. 904054-02-0

AUTEN-99( —— )

Catalog No. M16499 CAS No. 904054-02-0

A small molecule autophagy enhancer that inhibit the myotubularin-related phosphatase MTMR14/Jumpy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    AUTEN-99
  • Note
    Research use only, not for human use.
  • Brief Description
    A small molecule autophagy enhancer that inhibit the myotubularin-related phosphatase MTMR14/Jumpy.
  • Description
    A small molecule autophagy enhancer that inhibit the myotubularin-related phosphatase MTMR14/Jumpy; induces autophagic flux and promotes cell survival in mammalian cell cultures; increases the number of autophagic structures in mice and Drosophila, and effectively penetrates through a blood-brain barrier model; impedes the progression of neurodegenerative symptoms in Drosophila models of Parkinson's and Huntington's diseases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    Autophagy
  • Recptor
    Autophagy
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    904054-02-0
  • Formula Weight
    278.373
  • Molecular Formula
    C17H14N2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    2-([1,1'-biphenyl]-4-yl)-5,6-dihydroimidazo[2,1-b]thiazole

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kovács T, et al. Sci Rep. 2017 Feb 16;7:42014.
molnova catalog
related products
  • CLK1-IN-3

    Clk1-in-3 is a + selective and highly potent sexual Clk1 inhibitor with an IC50 of 5 nM and 300 pairs higher affinity than Dyrk1A.

  • SP-8356

    SP-8356 is a potent, orally active inhibitor of cluster of differentiation 147 (CD147) with anti-atherosclerotic effects.

  • UVI 3003

    UVI 3003 is a highly selective antagonist of the retinoid X receptor. UVI 3003 inhibits Xenopus and human RXRα in Cos7 cells (IC50s: 0.22 and 0.24 μM, respectively).